0000899243-21-001367.txt : 20210111 0000899243-21-001367.hdr.sgml : 20210111 20210111173617 ACCESSION NUMBER: 0000899243-21-001367 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210107 FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zawel Leigh CENTRAL INDEX KEY: 0001837456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39856 FILM NUMBER: 21521798 MAIL ADDRESS: STREET 1: C/O CULLINAN MANAGEMENT, INC. STREET 2: ONE MAIN STREET SUITE 520 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cullinan Management, Inc. CENTRAL INDEX KEY: 0001789972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813867811 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 520 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-410-4650 MAIL ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 520 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Cullinan Oncology, LLC DATE OF NAME CHANGE: 20191001 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-07 0 0001789972 Cullinan Management, Inc. CGEM 0001837456 Zawel Leigh C/O CULLINAN MANAGEMENT, INC. ONE MAIN STREET, SUITE 520 CAMBRIDGE MA 02142 0 1 0 0 See Remarks Stock Option (Right to Buy) 21.00 2021-01-07 4 A 0 56666 0.00 A 2031-01-06 Common Stock 56666 56666 D The option represents a right to purchase a total of 56,666 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on January 7, 2022, with the remaining shares vesting in equal monthly installments over the following three years (36 months), subject to the reporting person's continued employment with the Issuer. Chief Scientific Officer, Small Molecules /s/ Jeffrey Trigilio, Attorney-in-Fact 2021-01-07